droplet digital PCR
Bio-Rad Laboratories, Stilla Technologies Settle IP Lawsuit
Bio-Rad had alleged Stilla's Naica digital PCR system infringed on four patents held or licensed by the firm.
SARS-CoV-2 Study Implicates Saliva in Viral Transmission
Viral entry factors were broadly enriched in the salivary glands and oral mucosae, implicating the oral cavity as an important infection site.
Circulating Tumor DNA Provides Prognostic Clues in Advanced BRAF-Mutated Melanoma Cases
Using the BRAF-V600 tumor mutation as a marker, investigators identified pre-treatment and on-treatment ties between ctDNA and patient outcomes.
Bio-Rad Q3 Revenues Jump 15 Percent
Bio-Rad's year-over-year Q3 revenue increase was driven primary by sales of PCR and Droplet Digital PCR products due to the COVID-19 pandemic.
Biodesix Prices $72M IPO
Shares of the Boulder, Colorado-based firm will begin trading on the Nasdaq today under ticker symbol "BDSX" at $18 per share.
Apr 16, 2020
Feb 10, 2020
Aug 1, 2019
Bio-Rad Q2 Revenues Down 1 Percent
May 8, 2019
Bio-Rad Laboratories Reports Flat Q1 Revenues
Feb 28, 2019
Bio-Rad Q4 Revenues Down 1 Percent, Beat Estimates
Feb 22, 2019
Nov 1, 2018
Oct 25, 2018
Aug 7, 2018